发明名称 PYRIDYLISOXAZOLE DERIVATIVES
摘要 This invention offers isoxazole derivatives represented by the following formula (I) (see formula I) in which R1 and R2 each stands for hydrogen, lower alkyl, amino and the like; R3 stands for substituted or unsubstituted aryl or hetero aryl; R4 stands for hydrogen or lower alkyl; R5 stands for substituted or unsubstituted phenyl, furyl and the like; and Y stands for -CH2-, -CO-, -O-, -NH- and the like, or pharmaceutically acceptable salts thereof which exhibit excellent p38MAPkinase-inhibiting action with reduced side-effects, and useful for treating such diseases as chronic rheumatoid arthritis, ulcerative colitis and the like.
申请公布号 CA2656159(C) 申请公布日期 2014.12.16
申请号 CA20072656159 申请日期 2007.06.26
申请人 ASKA PHARMACEUTICAL CO., LTD. 发明人 HASUMI, KOICHI;OHTA, SHUJI;SAITO, TAKAHISA;SATO, SHUICHIRO;KATO, JUN-YA;SATO, JUN;SUZUKI, HIROYUKI;ASANO, HAJIME;OKADA, MAMI;MATSUMOTO, YASUHIRO;SHIROTA, KAZUHIKO
分类号 C07D413/04;A61K31/4439;A61P1/04;A61P1/16;A61P3/10;A61P9/10;A61P9/12;A61P11/00;A61P11/02;A61P11/06;A61P13/12;A61P15/06;A61P17/00;A61P17/06;A61P19/02;A61P19/06;A61P19/08;A61P19/10;A61P25/28;A61P29/00;A61P31/00;A61P31/04;A61P31/06;A61P31/18;A61P35/00;A61P35/04;A61P37/02;A61P37/08;A61P43/00;C07D413/14 主分类号 C07D413/04
代理机构 代理人
主权项
地址